Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

3.5K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.5K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.7K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

7.0K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
7.0K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
Lipid Catabolism01:25

Lipid Catabolism

1.4K
Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
1.4K
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

53
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
53

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The first heart beats and the beginning of the embryonic circulation.

American scientist·2014
Same author

Fusion of notochord to neural tube in a human embryo of the sixth week.

The Anatomical record·2010
Same author

Embryological stages in the development of spina bifida and myeloschisis.

The Anatomical record·2010
Same author

Local overgrowth as a possible factor in embryological malformations of the brain.

The Anatomical record·2010
Same author

Developmental defects at the foramen ovale.

The American journal of pathology·2009
Same author

PHOTOREACTIONS OF PARTIALLY BLINDED WHIP-TAIL SCORPIONS.

The Journal of general physiology·2009

Related Experiment Video

Updated: May 1, 2026

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
07:12

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment

Published on: June 2, 2023

6.5K

Hepatitis-associated lipid storage myopathy

B M Patten, J M Shabot, J Alperin

    Annals of Internal Medicine
    |October 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Hepatitis B virus infection can cause lipid storage myopathy, a condition characterized by muscle pain and lipid accumulation. Treatment with prednisone effectively resolved symptoms, suggesting a non-carnitine-deficient cause.

    More Related Videos

    Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
    07:03

    Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

    Published on: July 19, 2024

    1.9K
    Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
    06:26

    Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

    Published on: July 18, 2025

    1.2K

    Related Experiment Videos

    Last Updated: May 1, 2026

    Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
    07:12

    Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment

    Published on: June 2, 2023

    6.5K
    Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
    07:03

    Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

    Published on: July 19, 2024

    1.9K
    Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
    06:26

    Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

    Published on: July 18, 2025

    1.2K

    Area of Science:

    • Hepatology
    • Neurology
    • Immunology

    Background:

    • Hepatitis B virus (HBV) infection is a significant global health concern.
    • Lipid storage myopathies are a group of rare genetic disorders affecting muscle function.
    • The association between viral infections and myopathies is not fully understood.

    Observation:

    • A 23-year-old woman presented with severe myalgias (muscle pain).
    • She had concurrent mild hepatitis B surface antigen-positive hepatitis.
    • Muscle biopsy revealed numerous microvacuoles containing neutral lipids.

    Findings:

    • The patient's muscle carnitine levels were normal, ruling out carnitine deficiency.
    • Prednisone therapy led to complete resolution of myalgias and hepatitis.
    • This suggests a non-carnitine-deficient lipid storage myopathy induced by HBV.

    Implications:

    • Hepatitis B virus infection can trigger a distinct form of lipid storage myopathy.
    • This case highlights the potential for viral infections to induce metabolic myopathies.
    • Further research is warranted to elucidate the pathogenic mechanisms involved.